Orthofix International N.V. (NASDAQ: OFIX) announced today that
Scott Dodson has been promoted to the position of President of the
Orthopedics Global Business Unit (GBU). Mr. Dodson joined Orthofix in
2006 as the Global Vice President of Marketing for Orthopedics.
Previously Mr. Dodson was Vice President of Marketing at the Endoscopy
division of Boston Scientific.
"During the past year with Orthofix, Scott has been a significant
contributor to the improvement of our orthopedic business," said
Orthofix's Chief Executive Officer, Alan Milinazzo. "Scott is the
ideal person to lead the development of our global orthopedics
business and execute our long term growth strategy in this important
part of our core operations."
Additionally, Orthofix announced that Andrew Miclot has joined the
company as Vice President of Marketing for the Orthopedics GBU. Mr.
Miclot was previously a Senior Vice President at Symmetry Medical,
Inc., where he was responsible for sales, marketing and business
development for two divisions with 13 global locations and almost
2,000 employees. While at Symmetry Medical, Mr. Miclot directed a
number of strategic corporate initiatives, including several global
acquisitions. He also led efforts to build sales infrastructure,
worldwide distribution and customer service networks, and marketing
and R&D functions. Prior to that, Mr. Miclot was the Director of the
Medical Products Group at DePuy, an international division of Johnson
and Johnson.
"Andrew is an outstanding addition to our Orthopedic GBU, where
his experience in directing the implementation of various global
corporate initiatives will be important as we continue to execute the
organic and inorganic components of our long term growth strategy,"
stated Mr. Milinazzo.
About Orthofix International, N.V.
Orthofix International N.V., a global diversified orthopedic
products company, offers a broad line of minimally invasive surgical,
as well as non-surgical, products for the spine, orthopedics, and
sports medicine market sectors that address the lifelong
bone-and-joint health needs of patients of all ages, helping them
achieve a more active and mobile lifestyle. Orthofix's products are
widely distributed around the world to orthopedic surgeons and
patients via Orthofix's sales representatives and its subsidiaries,
including Breg, Inc. and Blackstone Medical, Inc., and via
partnerships with other leading orthopedic product companies,
including Kendall Healthcare. In addition, Orthofix is collaborating
in R&D partnerships with leading medical institutions such as the
Orthopedic Research and Education Foundation, Rutgers University, the
Cleveland Clinic Foundation, and National Osteoporosis Institute. For
more information about Orthofix, please visit www.orthofix.com.
